- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of… Read More..

DALLAS, May 15, 2023--(BUSINESS WIRE)--Blackboxstocks Inc. (NASDAQ: BLBX), ("Blackbox" or the "Company"), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the Company’s financial results for the first quarter of 2023, ended March 31, 2023. First Quarter… Read More..

SSII is a Developer of Innovative, Affordable and Accessible Surgical Robotic Technologies Fort Lauderdale, FL --News Direct-- SS Innovations International Inc SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable… Read More..